Maravai Lifesciences Holdings Total Assets Growth & History (MRVI)
Maravai Lifesciences Holdings's total assets was $770.6M for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $770.6M | −$237.7M | −23.57% |
| 2024 | 2024-12-31 | $1.01B | −$479.2M | −32.22% |
| 2023 | 2023-12-31 | $1.49B | −$794.9M | −34.83% |
| 2022 | 2022-12-31 | $2.28B | $364.0M | +18.98% |
| 2021 | 2021-12-31 | $1.92B | $647.6M | +50.96% |
| 2020 | 2020-12-31 | $1.27B | — | — |
Maravai Lifesciences Holdings quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $603.7M | −$293.2M | −32.69% |
| Q1 2026 | 2026-03-31 | $713.2M | −$246.5M | −25.69% |
| Q4 2025 | 2025-12-31 | $770.6M | −$237.7M | −23.57% |
| Q3 2025 | 2025-09-30 | $849.2M | −$429.1M | −33.57% |
| Q2 2025 | 2025-06-30 | $897.0M | −$546.8M | −37.87% |
| Q1 2025 | 2025-03-31 | $959.8M | −$484.9M | −33.56% |
| Q4 2024 | 2024-12-31 | $1.01B | −$479.2M | −32.22% |
| Q3 2024 | 2024-09-30 | $1.28B | −$989.3M | −43.63% |
| Q2 2024 | 2024-06-30 | $1.44B | −$820.7M | −36.24% |
| Q1 2024 | 2024-03-31 | $1.44B | −$870.7M | −37.61% |
| Q4 2023 | 2023-12-31 | $1.49B | −$794.9M | −34.83% |
| Q3 2023 | 2023-09-30 | $2.27B | $18.7M | +0.83% |
| Q2 2023 | 2023-06-30 | $2.26B | $92.6M | +4.27% |
| Q1 2023 | 2023-03-31 | $2.32B | $272.2M | +13.32% |
| Q4 2022 | 2022-12-31 | $2.28B | $364.0M | +18.98% |
| Q3 2022 | 2022-09-30 | $2.25B | $354.2M | +18.70% |
| Q2 2022 | 2022-06-30 | $2.17B | $570.6M | +35.63% |
| Q1 2022 | 2022-03-31 | $2.04B | $691.5M | +51.15% |
| Q4 2021 | 2021-12-31 | $1.92B | $647.6M | +50.96% |
| Q3 2021 | 2021-09-30 | $1.89B | — | — |
| Q2 2021 | 2021-06-30 | $1.60B | — | — |
| Q1 2021 | 2021-03-31 | $1.35B | — | — |
| Q4 2020 | 2020-12-31 | $1.27B | — | — |
Maravai Lifesciences Holdings total assets trends
Over the last five fiscal years, Maravai Lifesciences Holdings's total assets decreased from $1.27B to $770.6M, a change of −$500.1M. The latest reported quarter, Q2 2026, shows $603.7M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings source filings ↗